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Introduction {#ams2374-sec-0005}
============

Globally, out‐of‐hospital cardiac arrest occurs in approximately 20--140 people per 100,000 population per year.[1](#ams2374-bib-0001){ref-type="ref"} Despite advances in the resuscitation and management of patients in the post‐cardiac arrest period, many patients, including those who are initially resuscitated, die before discharge from the hospital, or are discharged with poor neurological status due to development of post‐cardiac arrest syndrome (PCAS).[2](#ams2374-bib-0002){ref-type="ref"} However, predicting patient prognosis, including neurological outcome, both of which are required to determine mild hypothermia (MHT) strategies following PCAS, is difficult.

Although neuron‐specific enolase is known to be a predictive marker of neurological outcome in PCAS patients and shows high accuracy in predicting neurological outcome on day 4,[3](#ams2374-bib-0003){ref-type="ref"} the number of facilities that can immediately measure neuron‐specific enolase are limited.

Recently, the relationship between lymphopenia in the acute phase and prognosis of PCAS patients was reported. One study showed that the neutrophil--lymphocyte ratio (NLR) is associated with mortality in cardiac arrest patients at admission.[4](#ams2374-bib-0004){ref-type="ref"}, [5](#ams2374-bib-0005){ref-type="ref"} Another study showed that lymphopenia occurs in PCAS patients at admission and is associated with neurological recovery in out‐of‐hospital cardiac arrest patients.[6](#ams2374-bib-0006){ref-type="ref"} However, the association between lymphocyte count and prognosis in the subacute phase (after day 2) is not well known.

In PCAS, whole‐body ischemia and reperfusion is associated with the development of systemic inflammatory response syndrome and elevation of plasma cytokine levels.[7](#ams2374-bib-0007){ref-type="ref"}

This phenomenon is considered to share features with sepsis, which causes elevation of plasma cytokine levels, and with stroke, which causes ischemia and reperfusion of the brain. Clinically, in patients with sepsis, lymphopenia on day 4, but not day 1, due to apoptosis of lymphocytes can be used as a predictor of mortality;[8](#ams2374-bib-0008){ref-type="ref"}, [9](#ams2374-bib-0009){ref-type="ref"} in stroke patients, lymphopenia at admission and day 4 is reportedly associated with stroke area.[10](#ams2374-bib-0010){ref-type="ref"}, [11](#ams2374-bib-0011){ref-type="ref"} Given the similarities of PCAS with stroke and sepsis in terms of their association with lymphopenia, lymphocyte count in both the acute and subacute phase might be associated with mortality and neurological outcome in PCAS patients.

Here, we retrospectively examined the association between lymphocyte count in the first 6 days after cardiac arrest and mortality or neurologic outcomes in PCAS patients treated with MHT.

Methods {#ams2374-sec-0006}
=======

Study design and setting {#ams2374-sec-0007}
------------------------

We retrospectively investigated patients (\>18 years old) at Shiga University of Medical Science (Otsu, Japan) who were successfully resuscitated following cardiac arrest and in whom MHT was induced between February 2011 and December 2016.

All patients developed unconsciousness (Glasgow Coma Scale \[GCS\] score \< 8) after return of spontaneous circulation (ROSC). Exclusion criteria for MHT were aortic dissection, hemorrhagic disease and pregnancy, and exclusion criteria for study participation were death within 72 h, stroke, and hematological and autoimmune diseases, which would prevent evaluation of neurological outcome and can cause lymphopenia, respectively.

All patients received standardized medical treatment along with MHT to 35°C for 48 h and were rewarmed over 24 h, according to our local treatment guidelines.

Repeated neurological examinations were undertaken at least 48 h after cardiac arrest, after rewarming the patient to a core temperature of \>36°C and when the patient was off sedation. This study was approved by the institutional review board of Shiga University of Medical Science (29‐042) and carried out in accordance with the principles of the Declaration of Helsinki (amended in 2013). We publicized the study by posting a summary of the protocol on the website of the Shiga University of Medical Science and the notice clearly informed patients of their right to refuse participation.

Measurements and data collection {#ams2374-sec-0008}
--------------------------------

We collected patient demographic data and information on other baseline characteristics, including age, sex, body mass index, cardiopulmonary resuscitation (initial cardiac rhythm, time to ROSC, witness report, provision of bystander cardiopulmonary resuscitation, etiology of cardiac arrest, provision of defibrillation, total adrenaline dose, and prehospital ROSC), and Sequential Organ Failure Assessment (SOFA) score for the first 6 days (excluding the GCS score). Based on previous studies, we estimated catecholamine doses, as the catecholamine index (CAI), hourly for each of the first 6 days using the formula: CAI = hourly doses (μg/kg/min) of dopamine + dobutamine + (adrenaline + noradrenaline) × 100 (μg/kg/min). The CAI of each day was calculated at the highest point of the day. Ninety‐day mortality, laboratory results, and neurological outcome were assessed on the basis of the cerebral performance categories (CPC) score.[12](#ams2374-bib-0012){ref-type="ref"}, [13](#ams2374-bib-0013){ref-type="ref"} The CPC score was retrospectively determined from the patients' discharge charts. We defined CPC 1‐2 as favorable outcomes and CPC 3--5 as unfavorable outcomes.

Blood samples were collected daily for the first 6 days in all patients. Blood sampling on day 1 was defined as the value measured for the first 24 h after admission to the intensive care unit.

Outcomes {#ams2374-sec-0009}
--------

The primary outcomes evaluated were 90‐day mortality and neurological status at 90 days.

Data analysis {#ams2374-sec-0010}
-------------

Statistical analyses were carried out with the IBM [spss]{.smallcaps} Statistics 22 software package (IBM Japan, Tokyo, Japan). Variables are expressed as the median and interquartile range for continuous variables and proportion for categorical variables. Demographic and clinical differences between groups were assessed using Student\'s *t*‐test or the Mann--Whitney *U*‐test, as appropriate. Lymphocyte counts, neutrophil counts, white blood cell (WBC) counts, C‐reactive protein (CRP) levels and NLR, which are related to inflammation, SOFA score (excluding GCS) and CAI were compared between favorable and unfavorable neurological outcome groups, and between survivors and non‐survivors, using repeated‐measures [anova]{.smallcaps}. Logistic regression analysis was carried out to assess the correlations between neurological outcomes and survival with lymphocyte count on days 1--6 and other candidate risk factors, such as age, time to ROSC, SOFA score without GCS on day 1, and shockable rhythm. All variables and risk factors initially considered in the univariate logistic analysis to be significantly associated with mortality or neurological outcome (*P* \< 0.10) were included in multivariate logistic regression analysis. For the final model, we calculated the adjusted odds ratio and 95% confidence intervals for each variable. *P* \< 0.05 was considered significant. The predictive accuracy of lymphocyte counts and NLR on each day for neurological outcome was calculated using analysis of the area under the receiver operating characteristic curve.

Univariate linear analysis was carried out to evaluate the relationship between the lymphocyte count on each day and candidate variables, such as age, time to ROSC, SOFA score on day 1 and catecholamine index on each day using univariate linear regression. We also undertook multivariate linear regression analysis to evaluate the relationship between lymphocytes and combinations of risk factors. We included all risk factors that were significantly associated with lymphocyte counts (*P* \< 0.10) in the univariate analysis.

Results {#ams2374-sec-0011}
=======

A total of 46 cardiac arrest patients, all of whom received MHT and survived for more than 72 h, were enrolled in this study. There were no mortalities from days 3 to 6 in this study. The main characteristics of survivors and non‐survivors are shown in Table [1](#ams2374-tbl-0001){ref-type="table"}. Overall survival was seen in 27 patients. In survivors, the time to ROSC was shorter, dosage of adrenaline at resuscitation was lower, proportion of prehospital ROSC was higher, SOFA score without GCS on day 1 was lower, and CAI on days 5 and 6 were lower than in non‐survivors. There were no significant differences in the proportion of shockable rhythms between survivors and non‐survivors (Table [1](#ams2374-tbl-0001){ref-type="table"}).

###### 

Comparison of baseline characteristics between survivors and non‐survivors among Japanese patients with coma after cardiac arrest (*n* = 46)

                                         Total (*n* = 46)     Survivors (*n* = 33)   Non‐survivors (*n* = 13)   *P*‐value
  -------------------------------------- -------------------- ---------------------- -------------------------- -----------
  Age, years                             62.0 (48.5--71.3)    59.0 (39.0--71.0)      64.0 (60.5--73.0)          0.113
  Sex, male                              38 (83)              26 (79)                11 (85)                    0.182
  BMI                                    22.2 (18.4--24.2)    21.7 (17.9--23.5)      23.2 (20.2--28.1)          0.054
  Initial rhythm of VT/VF                26 (57)              19 (58)                7 (54)                     0.818
  Time from collapse to ROSC, min        30.5 (18.0--50.0)    24.0 (14.0--45.0)      47.5 (28.3--57.0)          0.018
  Witnessed cardiac arrest               43 (94)              30 (91)                13 (100)                   0.261
  Adrenaline dose at resuscitation, mg   3 (0.0--4.0)         1 (0.0--3.5)           4 (3.0--5.0)               0.004
  Provision of defibrillation            25 (54)              19 (58)                6 (46)                     0.484
  Prehospital ROSC                       14 (30)              13 (39)                1 (8)                      0.035
  In‐hospital cardiac arrest             11 (24)              6 (18)                 5 (38)                     0.147
  Bystander CPR                          19 (41)              23 (70)                5 (38)                     0.051
  Cardiac origin of arrest               32 (70)              23 (70)                9 (69)                     0.975
  Coronary disease                       15 (33)              9 (27)                 6 (46)                     0.206
  CAI                                                                                                           
  Day 1                                  5.00 (2.00--12.48)   5.00 (1.00--12.00)     8.00 (2.00--21.25)         0.087
  Day 2                                  4.50 (1.23--9.25)    3.70 (5.00--8.00)      6.00 (2.50--12.50)         0.053
  Day 3                                  3.00 (0.25--8.00)    2.50 (0.00--7.50)      8.00 (1.50--8.00)          0.053
  Day 4                                  2.00 (0.00--5.63)    2.00 (0.00--5.00)      4.00 (0.00--8.00)          0.269
  Day 5                                  1.10 (0.00--4.13)    0.00 (0.00--3.00)      4.00 (0.00--11.50)         0.025
  Day 6                                  0.00 (0.00--3.00)    0.00 (0.00--1.65)      3.00 (0.00--9.50)          0.022

Data are shown as median (range) or *n* (%).

Catecholamine index (CAI) = hourly doses (μg/kg/min) of dopamine + dobutamine + (adrenaline + noradrenaline) × 100 (μg/kg/min).

CAI of each day was calculated at the highest point of the day.

BMI, body mass index; CPR, cardiopulmonary resuscitation; ROSC, return of spontaneous circulation; VF, ventricular fibrillation; VT, ventricular tachycardia.
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Survivors had a significantly higher WBC count on day 2 and lymphocyte counts on days 2 and 5, and lower CRP on days 4--6, NLR on day 6, neutrophil counts on day 1 and SOFA scores on days 1--6, compared with non‐survivors (Fig. [1](#ams2374-fig-0001){ref-type="fig"}). Univariate analysis of mortality found the following additional variables to be statistically significantly related to survival: lymphocyte count on days 2, 5 and 6, age, SOFA score without GCS on day 1, and time to ROSC. Multivariate logistic analysis of each lymphocyte count revealed that none of these variables was associated with mortality (Table [2](#ams2374-tbl-0002){ref-type="table"}).

![Comparison of white blood cell count, C‐reactive protein levels, lymphocyte count, neutrophil count, neutrophil--lymphocyte ratio (NLR) and Sequential Organ Failure Assessment (SOFA) scores between survivor (solid line) and non‐survivor (broken line) outcome groups of Japanese patients with coma after cardiac arrest (*n* = 46). The values of each point are shown below the graphs. The average of survivors is shown in the upper line of values; the average of non‐survivors is shown in the lower line of values. Whiskers in the graphs indicate standard deviation. SOFA score excluded Glasgow Coma Scale (GCS) score. \**P* \< 0.05 compared with survivors.](AMS2-6-30-g001){#ams2374-fig-0001}

###### 

Univariate and multivariate logistic regression analyses of mortality among Japanese patients with coma after cardiac arrest (*n* = 46)

  Lymphocyte count, 100/μL           Univariate analysis                  Multivariate analysis                                                             
  ---------------------------------- --------------------- -------------- ----------------------- ---------------------------------- ------- -------------- -------
                                                                                                  Model 1                                                   
  Day 1                              0.910                 0.746--1.111   0.355                   Lymphocyte count on day 2          0.874   0.677--1.128   0.301
  Day 2                              0.840                 0.689--1.025   0.087                   SOFA score without GCS on day 1    1.064   0.719--1.575   0.756
  Day 3                              0.923                 0.750--1.137   0.453                   Age                                1.071   0.973--1.179   0.161
  Day 4                              0.789                 0.530--1.176   0.245                   Time from collapse to ROSC (min)   1.032   0.966--1.101   0.349
  Day 5                              0.768                 0.592--0.995   0.046                   Model 2                                                   
  Day 6                              0.798                 0.612--1.040   0.095                   Lymphocyte count on day 5          0.957   0.699--1.309   0.782
  SOFA score without GCS on day 1    1.437                 1.121--1.842   0.004                   SOFA score without GCS on day 1    1.275   0.879--1.849   0.201
  Age                                1.047                 0.998--1.100   0.063                   Age                                1.033   0.945--1.130   0.476
  Time from collapse to ROSC (min)   1.035                 0.999--1.072   0.059                   Time from collapse to ROSC (min)   1.054   0.985--1.128   0.129
  Initial rhythm of VT/VF            0.860                 0.236--3.125   0.818                   Model 3                                                   
                                                                                                  Lymphocyte count on day 6          0.908   0.659--1.253   0.557
                                                                                                  SOFA score without GCS on day 1    1.172   0.843--1.629   0.345
                                                                                                  Age                                1.022   0.944--1.107   0.591
                                                                                                  Time from collapse to ROSC (min)   1.025   0.986--1.065   0.218

Sequential organ failure assessment (SOFA) score without Glasgow Coma Scale (GCS) on day 1 was measured as the worst data within the first 24 h, excluding GCS score.

Model 1 included lymphocyte count on day 2, SOFA score on day 1, age and time from collapse to return of spontaneous circulation (ROSC), for which the *P*‐values were \< 0.1. Model 2 included lymphocyte count on day 5, SOFA score on day 1, age and time from collapse to ROSC, for which the *P*‐values were \< 0.1. Model 3 included lymphocyte count on day 6, SOFA score on day 1, age and time from collapse to ROSC, for which the *P*‐values were \< 0.1.

CI, confidence interval.

John Wiley & Sons, Ltd

The main characteristics of patients with favorable and unfavorable neurological outcomes are shown in Table [3](#ams2374-tbl-0003){ref-type="table"}. Overall favorable neurological outcome was seen in 19 patients. In patients with favorable neurological outcomes, the time to ROSC was shorter, and CAI on day 1 was lower than those in patients with unfavorable neurological outcomes. There were no significant differences in the proportion of shockable rhythms between patients with favorable and unfavorable neurological outcomes.

###### 

Comparison of baseline characteristics among Japanese patients with coma after cardiac arrest (*n* = 46), according to favorable and unfavorable outcomes

                                         Total (*n* = 46)     Favorable outcome (*n* = 19)   Unfavorable outcome (*n* = 27)   *P*‐value
  -------------------------------------- -------------------- ------------------------------ -------------------------------- -----------
  Age, years                             62.0 (48.5--71.3)    51.0 (34.0--68.0)              67.0 (59.0--74.0)                0.016
  Sex, male                              38 (83)              16 (84)                        22 (82)                          0.810
  BMI                                    22.2 (18.4--24.2)    22.8 (19.4--24.5)              21.7 (18.4--23.3)                0.292
  Initial rhythm of VT/VF                26 (57)              12 (63)                        14 (52)                          0.446
  Time from collapse to ROSC, min        30.5 (18.0--50.0)    24.0 (15.0--41.0)              45.0 (27.0--54.0)                0.018
  Witnessed cardiac arrest               43 (94)              19 (100)                       24 (89)                          0.133
  Adrenaline dose at resuscitation, mg   3.0 (0.0--4.0)       1.0 (0.0--4.0)                 3.0 (1.0--5.0)                   0.072
  Provision of defibrillation            25 (54)              11 (58)                        14 (52)                          0.685
  Prehospital ROSC                       14 (30)              8 (42)                         6 (22)                           0.149
  In‐hospital cardiac arrest             11 (24)              4 (21)                         7 (26)                           0.703
  Bystander CPR                          19 (41)              11 (58)                        8 (30)                           0.055
  Cardiac origin of arrest               32 (70)              15 (79)                        17 (63)                          0.246
  Coronary disease                       15 (33)              7 (37)                         8 (30)                           0.607
  CAI                                                                                                                         
  Day 1                                  5.00 (2.00--12.48)   4.00 (0.00--12.00)             8.00 (2.00--16.00)               0.042
  Day 2                                  4.50 (1.23--9.25)    2.50 (0.10--8.00)              5.00 (1.00--11.00)               0.533
  Day 3                                  3.00 (0.25--8.00)    4.00 (0.90--8.00)              3.00 (0.30--9.00)                0.796
  Day 4                                  2.00 (0.00--5.63)    2.00 (0.90--5.00)              2.00 (0.00--6.00)                0.697
  Day 5                                  1.10 (0.00--4.13)    0.00 (0.00--4.00)              2.00 (0.00--5.00)                0.173
  Day 6                                  0.00 (0.00--3.00)    0.00 (0.00--2.00)              0.00 (0.00--4.00)                0.163
  Survival                               33 (72)              18 (95)                        15 (56)                          0.004

Data are shown as median (range) or *n* (%).

Favorable outcome = cerebral performance category score 1--2; unfavorable outcome = score 3--5.

Catecholamine index (CAI) = hourly doses (μg/kg/min) of dopamine + dobutamine + (adrenaline + noradrenaline) × 100 (μg/kg/min).

CAI of each day was calculated at the highest point of the day.

BMI, body mass index; CPR, cardiopulmonary resuscitation; ROSC, return of spontaneous circulation; VF, ventricular fibrillation; VT, ventricular tachycardia.

John Wiley & Sons, Ltd

There were no significant differences in WBC count or CRP between patients in the favorable and unfavorable neurological outcome groups. Patients who had a favorable neurological outcome had significantly higher lymphocyte count on days 2--6, lower SOFA score on days 4--6, higher neutrophil count on day 1, lower neutrophil count on day 6 and lower NLR on day 6 than patients with unfavorable neurological outcomes (Fig. [2](#ams2374-fig-0002){ref-type="fig"}). Univariate analysis of neurological outcomes found the following factors to be statistically significant: lymphocyte count on days 2--6, age, SOFA score without GCS on day 1, and time to ROSC. Multivariate analysis of individual lymphocyte counts on days 2--6, age, SOFA score without GCS at admission and time to ROSC showed that each of the lymphocyte counts on days 2--4 and 6 were associated with neurological outcome, whereas lymphocyte counts on day 5 were not associated with neurological outcome (Table [4](#ams2374-tbl-0004){ref-type="table"}).

![Comparison of white blood cell count, C‐reactive protein levels, lymphocyte count, neutrophil count, neutrophil--lymphocyte ratio (NLR) and Sequential Organ Failure Assessment (SOFA) scores between favorable (solid line) and unfavorable (broken line) neurological outcome groups of Japanese patients with coma after cardiac arrest (*n* = 46). The values of each point are shown below the graph. The average of patients with favorable neurological outcome is shown in the upper line of values; the average of patients with unfavorable neurological outcome is shown in the lower line of values. The whiskers indicate standard deviation. SOFA score excluded Glasgow Coma Scale (GCS) score. \**P* \< 0.05 compared with the favorable outcome group. CPC, cerebral performance category.](AMS2-6-30-g002){#ams2374-fig-0002}

###### 

Univariate and multivariate logistic regression analyses of neurological outcome among Japanese patients with coma after cardiac arrest (*n* = 46)

  Lymphocyte count, 100/μL           Univariate analysis                  Multivariate analysis                                                             
  ---------------------------------- --------------------- -------------- ----------------------- ---------------------------------- ------- -------------- -------
                                                                                                  Model 1                                                   
  Day 1                              0.877                 0.727--1.059   0.172                   Lymphocyte count on day 2          0.753   0.583--0.972   0.029
  Day 2                              0.824                 0.693--0.980   0.029                   SOFA score without GCS on day 1    0.861   0.586--1.265   0.447
  Day 3                              0.770                 0.593--1.000   0.050                   Age                                1.075   0.986--1.177   0.099
  Day 4                              0.432                 0.200--0.935   0.033                   Time from collapse to ROSC (min)   1.086   1.003--1.177   0.043
  Day 5                              0.769                 0.618--0.957   0.019                   Model 2                                                   
  Day 6                              0.683                 0.510--0.914   0.010                   Lymphocyte count on day 3          0.679   0.470--0.983   0.040
  SOFA score without GCS on day 1    1.224                 1.011--1.482   0.039                   SOFA score without GCS on day 1    0.889   0.488--1.619   0.701
  Age                                1.047                 1.008--1.087   0.019                   Age                                1.120   0.986--1.271   0.081
  Time from collapse to ROSC (min)   1.044                 1.005--1.084   0.025                   Time from collapse to ROSC (min)   1.084   0.982--1.196   0.110
  Initial rhythm of VT/VF            0.628                 0.189--2.085   0.447                   Model 3                                                   
                                                                                                  Lymphocyte count on day 4          0.400   0.160--1.000   0.050
                                                                                                  SOFA score without GCS on day 1    1.383   0.647--2.956   0.403
                                                                                                  Age                                0.987   0.898--1.085   0.789
                                                                                                  Time from collapse to ROSC (min)   1.053   0.955--1.162   0.296
                                                                                                  Model 4                                                   
                                                                                                  Lymphocyte count on day 5          0.791   0.593--1.055   0.111
                                                                                                  SOFA score without GCS on day 1    0.976   0.711--1.340   0.881
                                                                                                  Age                                1.053   0.980--1.119   0.169
                                                                                                  Time from collapse to ROSC (min)   1.075   0.996--1.159   0.062
                                                                                                  Model 5                                                   
                                                                                                  Lymphocyte count on day 6          0.687   0.475--0.993   0.046
                                                                                                  SOFA score without GCS on day 1    0.865   0.618--1.209   0.395
                                                                                                  Age                                1.063   0.996--1.135   0.066
                                                                                                  Time from collapse to ROSC (min)   1.026   0.972--1.084   0.349

Sequential organ failure assessment (SOFA) score without Glasgow Coma Scale (GCS) on day 1 was measured as the worst data within the first 24 h, excluding GCS score.

Model 1 included lymphocyte count on day 2, SOFA score on day 1, age and time from collapse to return of spontaneous circulation (ROSC), for which the *P*‐values were \< 0.1. Model 2 included lymphocyte count on day 3, SOFA score on day 1, age and time from collapse to ROSC, for which the *P*‐values were \< 0.1. Model 3 included lymphocyte count on day 4, SOFA score on day 1, age and time from collapse to ROSC, for which the *P*‐values were \< 0.1. Model 4 included lymphocyte count on day 5, SOFA score on day 1, age and time from collapse to ROSC, for which the *P*‐values were \< 0.1. Model 5 included lymphocyte count on day 6, SOFA score on day 1, age and time from collapse to ROSC, for which the *P*‐values were \< 0.1.

CI, confidence interval.
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Receiver operating characteristic curves showed a high accuracy for each lymphocyte count and neutrophil--lymphocyte ratio on days 2--6 to predict neurological outcome (Table [5](#ams2374-tbl-0005){ref-type="table"}).

###### 

Receiver operating characteristic curve analysis of neurological outcome among Japanese patients with coma after cardiac arrest (*n* = 46)

                                    AUC     *P*‐value   95% CI
  --------------------------------- ------- ----------- --------------
  Lymphocyte counts, /μL                                
  Day 1                             0.661   0.157       0.433--0.889
  Day 2                             0.776   0.018       0.592--0.960
  Day 3                             0.787   0.017       0.605--0.969
  Day 4                             0.909   0.002       0.773--1.000
  Day 5                             0.774   0.012       0.591--0.957
  Day 6                             0.839   0.002       0.689--0.989
  NLR                                                   
  Day 1                             0.572   0.526       0.348--0.796
  Day 2                             0.739   0.040       0.541--0.938
  Day 3                             0.753   0.035       0.552--0.955
  Day 4                             0.800   0.020       0.607--0.993
  Day 5                             0.889   \>0.001     0.769--1.000
  Day 6                             0.911   \>0.001     0.810--1.000
  SOFA score without GCS on day 1   0.701   0.022       0.542--0.860
  Age                               0.710   0.018       0.549--0.870
  Time to ROSC (min)                0.707   0.018       0.557--0.856

Sequential Organ Failure Assessment (SOFA) score without Glasgow Coma Scale (GCS) on day 1 was measured as the worst data within the first 24 h, excluding GCS score.

AUC, area under the curve; CI, confidence interval; NLR, neutrophil--lymphocyte ratio; ROSC, return of spontaneous circulation.

John Wiley & Sons, Ltd

On days 2--4, lymphocyte count showed higher accuracy for prediction of neurological outcome than NLR. On days 5 and 6, NLR showed higher accuracy for prediction of neurological outcome than lymphocyte count. In univariate and multivariate linear regression analyses, SOFA score on day 1 was independently associated with lymphocyte count on days 1, 2, 5 and 6. In univariate linear regression analysis, CAI on day 4 was associated with lymphocyte count on day 4. The CAI on day 5 and time to ROSC were associated with lymphocyte count on day 5, although neither variable was associated with lymphocyte count in multivariate linear regression analysis (Table [6](#ams2374-tbl-0006){ref-type="table"}).

###### 

Univariate and multivariate logistic regression analyses of lymphocyte count among Japanese patients with coma after cardiac arrest (*n* = 46)

                                          Univariate linear regression   Multivariate linear regression                                       
  --------------------------------------- ------------------------------ -------------------------------- ------------------ -------- ------- ------------------
  Analysis of lymphocyte count on day 1                                                                                                       
  CAI on day 1                            −0.097                         0.434                            −0.154 to 0.348                     
  Age                                     −0.013                         0.822                            −0.135 to 0.108                     
  Time from collapse to ROSC (min)        −0.035                         0.306                            −0.104 to 0.034                     
  SOFA score without GCS on day 1         −0.521                         0.016                            −0.934 to −0.107                    
  Analysis of lymphocyte count on day 2                                                                                                       
  CAI on day 2                            0.126                          0.565                            −0.319 to 0.571                     
  Age                                     −0.021                         0.724                            −0.139 to 0.098                     
  Time from collapse to ROSC (min)        −0.036                         0.566                            −0.165 to 0.093                     
  SOFA score without GCS on day 1         −0.629                         0.024                            −1.168 to −0.090                    
  Analysis of lymphocyte count on day 3                                                                                                       
  CAI on day 3                            0.214                          0.386                            −0.289 to 0.714                     
  Time from collapse to ROSC (min)        −0.022                         0.739                            −0.158 to 0.113                     
  Age                                     −0.012                         0.831                            −0.132 to 0.107                     
  SOFA score without GCS on day 1         −0.403                         0.355                            −1.291 to 0.481                     
  Analysis of lymphocyte count on day 4                                                                                                       
  CAI on day 4                            −0.293                         0.081                            −0.612 to 0.039    −0.236   0.132   −0.551 to 0.079
  Time from collapse to ROSC (min)        −0.044                         0.133                            −0.103 to 0.015                     
  Age                                     −0.075                         0.052                            −0.150 to 0.001    −0.064   0.086   −0.138 to 0.010
  SOFA score without GCS on day 1         −0.087                         0.764                            −0.684 to 0.510                     
  Analysis of lymphocyte count on day 5                                                                                                       
  CAI on day 5                            −0.293                         0.066                            −0.607 to 0.021    −0.161   0.379   −0.530 to 0.209
  Time from collapse to ROSC (min)        −0.057                         0.100                            −0.126 to 0.012    −0.015   0.714   −0.096 to 0.066
  Age                                     −0.076                         0.103                            −0.169 to 0.016                     
  SOFA score without GCS on day 1         −0.528                         0.010                            −0.921 to −0.134   −0.439   0.041   −0.860 to −0.019
  Analysis of lymphocyte count on day 6                                                                                                       
  CAI on day 6                            −0.253                         0.166                            −0.618 to 0.111                     
  Time from collapse to ROSC (min)        −0.039                         0.262                            −0.108 to 0.030                     
  Age                                     −0.076                         0.078                            −0.162 to 0.009    −0.042   0.339   −0.130 to 0.046
  SOFA score without GCS on day 1         −0.528                         0.013                            −0.935 to −0.120   −0.446   0.049   −0.889 to −0.002

Sequential Organ Failure Assessment (SOFA) score without Glasgow Coma Scale (GCS) on day 1 was measured as the worst data within the first 24 h, excluding GCS score.

Catecholamine index (CAI) = hourly doses (μg/kg/min) of dopamine + dobutamine + (adrenaline + noradrenaline) × 100 (μg/kg/min).

CAI of each day was calculated at the highest point of the day.

B, partial regression coefficient; CI, confidence interval.
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Discussion {#ams2374-sec-0012}
==========

In this retrospective study, we showed that lymphocyte count on days 2‐4 and 6 were associated with neurological outcome, but not with mortality, in PCAS patients. Receiver operating characteristic curves of lymphocyte count on days 2--6 were able to predict neurological outcome, with lymphocyte count on day 4 showing the highest accuracy to predict neurological outcome.

Lymphopenia might be caused by lymphocytic apoptosis. Lymphopenia sometimes occurs in patients with sepsis and stroke, which have similar features to PCAS.[9](#ams2374-bib-0009){ref-type="ref"}, [10](#ams2374-bib-0010){ref-type="ref"} Lymphocyte apoptosis is a possible mechanism to explain the lymphopenia in both sepsis and stroke.[10](#ams2374-bib-0010){ref-type="ref"}, [14](#ams2374-bib-0014){ref-type="ref"} Lymphocytic apoptosis could also occur pathophysiologically in PCAS. In fact, lymphocyte apoptosis in the spleen has been identified in an animal PCAS model.[15](#ams2374-bib-0015){ref-type="ref"} Hence, apoptosis of lymphocytes might be the reason for the lymphopenia observed in the PCAS patients in our study.

Catecholamines might influence lymphocyte count in PCAS patients. One study reported that catecholamines are involved in proliferation of lymphocytes,[16](#ams2374-bib-0016){ref-type="ref"} whereas another study reported that catecholamines are involved in apoptosis of lymphocytes.[17](#ams2374-bib-0017){ref-type="ref"} In this study, extrinsic catecholamines were not independently associated with neurological outcome or lymphocyte count. However, it has been previously reported that intrinsic catecholamines are elevated in PCAS patients.[18](#ams2374-bib-0018){ref-type="ref"} Evaluation of the association between plasma catecholamine concentration and lymphocyte counts might reveal the mechanism of lymphopenia in PCAS patients.

An association between lymphopenia and mortality in sepsis patients was also observed in a previous study.[9](#ams2374-bib-0009){ref-type="ref"} However, in the current study, lymphopenia was not associated with mortality in PCAS patients, despite the PCAS‐induced cytokinemia, as is seen in sepsis. This suggests that immunosuppression accompanied by lymphopenia might be fatal in sepsis, which is related to infection, but is not fatal in PCAS, which is not related to infection at admission.

In our study, lymphocyte count on days 2--6 showed higher accuracy in predicting neurological outcome than that on day 1.There were five patients who had unfavorable neurological outcomes and a higher lymphocyte count than 675/μL (the median value for all patients) on day 1. Lymphocyte count in the subacute phase tended to decrease in four of these patients. This phenomenon might be one of the reasons lymphocyte count on day 4 showed a higher accuracy to predict neurological outcome than that on day 1.

In our study, NLR showed the highest accuracy in predicting neurological outcome on day 6. Only on day 6, neutrophil counts were significantly lower in patients who had favorable neurological outcomes than patients who had unfavorable neurological outcomes. This could be the reason why NLR on day 6 showed the highest accuracy in the prediction of neurological outcome.

Hypothermia is reported to cause lymphopenia.[19](#ams2374-bib-0019){ref-type="ref"} However, although lymphocyte counts on day 3 could have been influenced by MHT, those on days 4 and 5 were not. Therefore, the association between lymphocyte count and neurological outcome in PCAS patients in this study was most likely not an effect of the MHT.

There are several limitations to this study. First, it was retrospective in nature. Second, this was a single‐center study, so the sample size was relatively small. However, the statistical power for logistic analysis of lymphocyte counts on days 2--6 and neurological outcome, which was calculated assuming a type 1 error = 0.05, showed sample size and prognostic proportion to be as follows: day 1, 0.396; day 2, 0.868; day 3, 0.961; day 4, \>0.999; day 5, 0.885; and day 6, 0.986. The high statistical power might be the reason for the association between lymphocyte count on days 2--6 and neurological outcome, despite the small sample size. Third, our hospital is a tertiary care hospital. Hence, it is possible that only patients who are expected to have a favorable outcome with more intensive treatment are transported to our hospital for intensive care. This could be a reason for the more favorable neurological outcome in non‐ventricular fibrillation patients in our study compared with previous studies,[20](#ams2374-bib-0020){ref-type="ref"} and for the absence of association between neurological outcomes and initial cardiac rhythm. Finally, as our facility can measure neutrophil and lymphocyte counts only during the daytime, we missed several data points, and day 1 data were not always measured immediately after admission. This could be a reason why we could not find an association between lymphocyte and neutrophil counts on day 1 and mortality, as was shown in a previous study.[4](#ams2374-bib-0004){ref-type="ref"} Prospective multicenter studies are required to resolve these issues.

Conclusion {#ams2374-sec-0013}
==========

Lymphopenia on days 2--4 and 6 after cardiac arrest is associated with poor neurological outcomes, but not mortality. Lymphocyte count on day 4 showed the highest accuracy of days 1--6 to predict neurological outcome in patients with coma after cardiac arrest.
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